Explore evidence

1,700,000 inhabitantsTo date, 1.7 million children below fourteen years of age live with the Human Immunodeficiency virus (HIV).

GabonVIH/sidapublished 2024IDCasesPubMeddocument of 4 observations

25.8 %Diarrhea was observed in 25.8% of 62 HIV-2 patients.

GabonVIH/sidaobserved 2003-2013published 2014Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

33.3 %One-third of RR-TB patients was HIV-positive.

GabonVIH/sidaobserved 2014-2021published 2023Infectioneurope_pmcdocument of 5 observationsDOI 10.1007/s15010-022-01941-5

11.1 %Two out of 18 viruses (11.1%) from children treated with a first-line regimen had INSTI drug resistance mutations at codon 138 (E138K and E138T).

GabonVIH/sidapublished 2019The Journal of antimicrobial chemotherapyPubMeddocument of 4 observations

1.4 %The prevalence of residual HIV-1 infection among seronegative donors was 1.4%.

GabonVIH/sidaobserved 2020–2021published 2023BMC infectious diseasesPubMeddocument of 8 observations

90.9 %Sensitivities for the detection of HIV in blood donors were 90.9% for Alere DETERMINE, 81.8% for BIOSYNEX Exacto Pro HIV, and 81.8% for MEDIFF HIV 1&2 Serum/sang Total Cassette compared with COBAS 6000 e601.

GabonVIH/sidapublished 2019Journal of clinical laboratory analysiseurope_pmcdocument of 4 observationsDOI 10.1002/jcla.22824

23.8 %Among HIV-positive individuals aged 0–24 years in Gabon, viral suppression rates were 23.8% in the 0–7 years age group, 29.2% in the 8–15 years age group, and 42.6% in the 16–24 years age group.

GabonVIH/sidapublished 2026PathogensOpenAlexdocument of 6 observationsDOI 10.3390/pathogens15050502

2.16 infectionsThe mean number of sexually transmitted infections was 2.16 (standard deviation 1.35) in HIV-positive pregnant women.

Gabonsexually transmitted infections · VIH/sidapublished 2023Infectious diseases of povertyPubMeddocument of 7 observations

100 %The specificity of all RDTs for the detection of HIV and HBsAg was 100%.

Gabonhépatite B · VIH/sidapublished 2019Journal of clinical laboratory analysiseurope_pmcdocument of 4 observationsDOI 10.1002/jcla.22824

25 %In Lambaréné, Gabon, the mortality rate among TB/HIV coinfected patients was 25%.

Gabontuberculose · VIH/sidapublished 2016The American journal of tropical medicine and hygieneeurope_pmcdocument of 12 observationsDOI 10.4269/ajtmh.15-0668

6.3 %The seroprevalence of antibodies to HIV among pregnant women in Gabon was 6.3% in 2005.

GabonVIH/sidaobserved 2005published 2012BMC Infectious DiseasesOpenAlexdocument of 14 observationsDOI 10.1186/1471-2334-12-64

895 individualsOf the 1634 individuals placed on antiretroviral treatment (ART) in a rural district in Malawi between April 2003 and December 2004, 895 (55%) were offered community support.

GabonVIH/sidaobserved between April 2003 and December 2004published 2007Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 7 observations

24.67 %Among the overall 213 cervical cancer patients, 56 were HIV-positive, representing 24.67%.

Gaboncancer du col de l'utérus · VIH/sidaobserved January 2010 to April 2017published 2021Obstetrics and gynecology internationalPubMeddocument of 4 observations

780 cells/μLMean CD4 counts among HIV-positive individuals aged 0–24 years in Gabon declined significantly with age, from 780 cells/μL in the 0–8 years age group to 470 cells/μL in the 16–24 years age group.

GabonVIH/sidapublished 2026PathogensOpenAlexdocument of 6 observationsDOI 10.3390/pathogens15050502

3.48 log copies/mLAmong HSV-2 seronegative HIV-infected individuals, the mean HIV viral load was 3.48 ± 0.44 log copies/mL.

Gabonherpes simplex virus-2 · VIH/sidapublished 2020Tropical medicine and infectious diseasePubMeddocument of 7 observations

4.82 log copies/mLAmong HSV-2 seropositive HIV-infected individuals, the mean HIV viral load was 4.82 ± 0.83 log copies/mL.

Gabonherpes simplex virus-2 · VIH/sidapublished 2020Tropical medicine and infectious diseasePubMeddocument of 7 observations

14.6 %The treatment regimen AZT + 3TC + EFV was prescribed to 14.6% (97 out of 666) of the studied people living with HIV in Gabon.

GabonVIH/sidaobserved October 2019 to October 2022published 2025Tropical medicine and infectious diseasePubMeddocument of 5 observations

0.47 infectionsThe mean number of vector-borne infections was 0.47 (standard deviation 0.72) in HIV-negative pregnant women.

Gabonvector-borne infections · VIH/sidapublished 2023Infectious diseases of povertyPubMeddocument of 7 observations

18.8 %Among 16 sequenced HIV-1 samples, subtype A1 accounted for 18.8% of strains.

Gabonsubtype A1 · VIH/sidaobserved 2020–2021published 2023BMC infectious diseasesPubMeddocument of 8 observations

0.8 %Among HIV-positive individuals on antiretroviral treatment (ART) in a rural district in Malawi, the proportion who stopped ART was 0.8% for those offered community support and 3.3% for those without community support.

GabonVIH/sidaobserved between April 2003 and December 2004published 2007Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 7 observations

4.7 %HPV-16 prevalence among HIV-infected women in Ouagadougou was 4.7%.

GabonVIH/sidaobserved 2009–2010published 2011Acta tropicaeurope_pmcdocument of 8 observations

72.5 %72.5% of the fifty-one immigrant women were HIV-infected.

GabonVIH/sidapublished 2020PloS onePubMeddocument of 7 observations

The most representative viral clades among recently-diagnosed blood donors in Gabon were CRF02_AG and subtype A1.

GabonVIH/sidaobserved 2020-08-03 to 2021-08-31published 2024PloS onePubMeddocument of 4 observations

40 %A cross-sectional survey conducted in Gabon found that 40% of lactating mothers also breastfed other children than their own.

GabonVIH/sidapublished 2004AIDS (London, England)europe_pmcDOI 10.1097/00002030-200409030-00015

5.5 aORHIV-1 infection was associated with anal shedding of multiple HR-HPV, with an adjusted odds ratio of 5.5 (95% CI: 1.3–24.5) among men who have sex with men in Bamako, Mali.

Gabonmultiple HR-HPV · VIH/sidapublished 2021Infectious agents and cancerPubMeddocument of 10 observations